Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study. (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12885-019-6082-6
PubMed Identifier: 31464604
Publication URI: http://europepmc.org/abstract/MED/31464604
Type: Journal Article/Review
Volume: 19
Parent Publication: BMC cancer
Issue: 1
ISSN: 1471-2407